Trial · NCT04546724
Results by group128
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 128
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With a Seroprotective CHIKV Antibody Level for Baseline Negative Subjects 28 Days Post-vaccination | VLA1553 18-64 Years | 204 | Participants | ||
| Number of Participants With a Seroprotective CHIKV Antibody Level for Baseline Negative Subjects 28 Days Post-vaccination | Placebo 18-64 Years | 0 | Participants | ||
| Number of Participants With a Seroprotective CHIKV Antibody Level for Baseline Negative Subjects 28 Days Post-vaccination | VLA1553 ≥65 Years | 59 | Participants | ||
| Number of Participants With a Seroprotective CHIKV Antibody Level for Baseline Negative Subjects 28 Days Post-vaccination | Placebo ≥65 Years | 0 | Participants | ||
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 18-64 Years | Visit 2 - Day 8 | 13.6 | 95% Confidence Interval 12.22 to 15.23 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo 18-64 Years | Visit 2 - Day 8 | 10.2 | 95% Confidence Interval 9.92 to 10.50 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 ≥65 Years | Visit 2 - Day 8 | 13.4 | 95% Confidence Interval 11.05 to 16.31 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo ≥65 Years | Visit 2 - Day 8 | 10.0 | 95% Confidence Interval 10.0 to 10.0 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 18-64 Years | Visit 3 - Day 29 | 3273.7 | 95% Confidence Interval 2860.93 to 3746.04 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo 18-64 Years | Visit 3 - Day 29 | 10.1 | 95% Confidence Interval 9.89 to 10.33 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 ≥65 Years | Visit 3 - Day 29 | 3688.8 | 95% Confidence Interval 2938.94 to 4630.10 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo ≥65 Years | Visit 3 - Day 29 | 10.0 | 95% Confidence Interval 10.0 to 10.0 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 18-64 Years | Visit 4 - Day 85 | 1068.7 | 95% Confidence Interval 934.77 to 1221.82 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo 18-64 Years | Visit 4 - Day 85 | 10.0 | 95% Confidence Interval 10.0 to 10.0 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 ≥65 Years | Visit 4 - Day 85 | 1140.9 | 95% Confidence Interval 942.97 to 1380.31 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo ≥65 Years | Visit 4 - Day 85 | 10.7 | 95% Confidence Interval 9.71 to 11.78 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 18-64 Years | Visit 5 - Day 180 | 755.1 | 95% Confidence Interval 656.01 to 869.16 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo 18-64 Years | Visit 5 - Day 180 | 10.0 | 95% Confidence Interval 10.0 to 10.0 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | VLA1553 ≥65 Years | Visit 5 - Day 180 | 742.8 | 95% Confidence Interval 578.36 to 954.0 | Antibody Titers |
| CHIKV-specific Neutralizing Antibody Titers | Placebo ≥65 Years | Visit 5 - Day 180 | 10.0 | 95% Confidence Interval 10.0 to 10.0 | Antibody Titers |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04546724/results